Kristine A Borrison, MD
Obstetrics/Gynecology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 3
Offices
3 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Borrison’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G81367 · Current
Licensed to practise in California · since 1995 · expires 2027-04-30 · Medical College of Pennsylvania.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Los Gatos Surgical CenterAmbulatory Surgery Center · Los Gatos, CA0.16% owner since 2015 · accredited by AAAHCAccreditation Renewed6 inspections, 3 with deficiencies · last 2025-04-03
- Los Gatos Surgical CenterSan Jose, CA0.16% owner since 2015 · accredited by AAAHCClosed1 inspection · last 2021-08-10
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$30,249
Medicare paid this office $30,249 for 133 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 53 | $5,937 | $77 |
| Return visit (30+ min) | 41 | $5,643 | $109 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 60 | $2,868 | $48 |
| New patient visit (60+ min) | 15 | $2,848 | $190 |
| Long return visit (40+ min) | 11 | $2,245 | $173 |
See all 7 services
| Short return visit (20+ min) | 53 | $5,937 | $77 |
| Return visit (30+ min) | 41 | $5,643 | $109 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 60 | $2,868 | $48 |
| New patient visit (60+ min) | 15 | $2,848 | $190 |
| Long return visit (40+ min) | 11 | $2,245 | $173 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 12 | $1,677 | $120 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 33 | $642 | $15 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
133 Original Medicare patients in 2024. Average age 73 · Women 100% · Health risk score 0.76. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 56% · Coronary heart disease 24% · Diabetes 19% · Cancer 17% · Atrial fibrillation 11% · COPD 9% · Depression 9% · Chronic kidney disease 8%.
The office billed $138,865, Medicare allowed $40,223 and paid $30,249; for 341 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 133 | 341 | 73 | 0.76 | $138,865 | $30,249 |
| 2023 | 116 | 258 | 73 | 0.75 | $127,847 | $29,851 |
| 2022 | 102 | 215 | 71 | 0.70 | $77,119 | $20,425 |
| 2021 | 93 | 230 | 71 | 0.70 | $87,493 | $21,939 |
| 2020 | 80 | 235 | 71 | 0.78 | $93,162 | $20,538 |
| 2019 | 72 | 188 | 69 | 0.64 | $57,533 | $13,541 |
| 2018 | 74 | 165 | 71 | 0.68 | $55,330 | $11,849 |
| 2017 | 67 | 184 | 71 | 0.71 | $55,732 | $12,581 |
| 2016 | 71 | 163 | 69 | 0.60 | $64,219 | $14,478 |
| 2015 | 62 | 195 | 70 | 0.65 | $37,381 | $11,767 |
| 2014 | 60 | 156 | 69 | 0.57 | $22,478 | $10,130 |
| 2013 | 60 | 174 | 70 | 0.63 | $28,924 | $12,376 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 42 | $5,217 | $82 |
| Return visit (30+ min) | 29 | $3,966 | $117 |
| New patient visit (60+ min) | 17 | $2,987 | $176 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 51 | $2,437 | $48 |
| Administration of influenza virus vaccine | 11 | $407 | $37 |
2022: 4 services
| Short return visit (20+ min) | 47 | $5,149 | $77 |
| Return visit (30+ min) | 23 | $3,070 | $118 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 53 | $2,536 | $48 |
| New patient visit (60+ min) | 11 | $2,251 | $205 |
2021: 3 services
| Short return visit (20+ min) | 39 | $4,962 | $84 |
| Return visit (30+ min) | 30 | $3,980 | $114 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 39 | $1,919 | $49 |
2020: 5 services
| Short return visit (20+ min) | 38 | $2,859 | $61 |
| Return visit (30+ min) | 22 | $2,739 | $98 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 42 | $2,058 | $49 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 18 | $1,000 | $56 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 11 | $199 | $18 |
2019: 4 services
| Short return visit (20+ min) | 26 | $2,236 | $59 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 43 | $1,978 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 30 | $1,648 | $55 |
| Return visit (30+ min) | 17 | $1,638 | $86 |
2018: 3 services
| Short return visit (20+ min) | 27 | $1,958 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 43 | $1,902 | $44 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 23 | $1,235 | $54 |
2017: 4 services
| Short return visit (20+ min) | 32 | $3,162 | $66 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 38 | $1,745 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 31 | $1,723 | $56 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 16 | $342 | $21 |
2016: 4 services
| Short return visit (20+ min) | 29 | $2,438 | $61 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 39 | $1,767 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 25 | $1,384 | $55 |
| Return visit (30+ min) | 11 | $1,046 | $80 |
2015: 6 services
| Short return visit (20+ min) | 37 | $3,768 | $59 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 37 | $1,678 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 22 | $1,202 | $55 |
| Dxa bone density measurement of hip, pelvis, spine | 14 | $734 | $52 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 22 | $467 | $21 |
| Short return visit | 11 | $448 | $37 |
2014: 5 services
| Short return visit (20+ min) | 39 | $3,023 | $60 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 25 | $1,123 | $45 |
| Dxa bone density measurement of hip, pelvis, spine | 17 | $1,064 | $63 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 14 | $755 | $54 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 20 | $425 | $21 |
2013: 5 services
| Short return visit (20+ min) | 29 | $3,236 | $59 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 25 | $1,135 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 16 | $866 | $54 |
| Dxa bone density measurement of hip, pelvis, spine | 12 | $767 | $64 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 17 | $366 | $22 |
Drugs they prescribed that Part D paid
$20,296
Pharmacies billed $20,296 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
215 generic and 47 brand-name prescriptions · $20,296 in drug cost · 22 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 59 | $6,546 | $111 |
| Premarin | 11 | $3,411 | $310 |
| Yuvafem | 14 | $3,162 | $226 |
| Menostar | 13 | $2,003 | $154 |
| Estradiol (Twice Weekly) | 12 | $1,047 | $87 |
See all 8 drugs
| Estradiol | 59 | $6,546 | $111 |
| Premarin | 11 | $3,411 | $310 |
| Yuvafem | 14 | $3,162 | $226 |
| Menostar | 13 | $2,003 | $154 |
| Estradiol (Twice Weekly) | 12 | $1,047 | $87 |
| Clotrimazole-Betamethasone | 15 | $427 | $28 |
| Valacyclovir | 12 | $148 | $12 |
| Fluconazole | 25 | $145 | $6 |
Year by year
| 2024 | 262 | 107 | None | 18% | $20,296 |
| 2023 | 181 | 82 | None | 9% | $14,715 |
| 2022 | 206 | 78 | None | 12% | $22,460 |
| 2021 | 176 | 66 | None | 16% | $16,843 |
| 2020 | 187 | 54 | None | 20% | $20,315 |
| 2019 | 145 | 41 | 0% (0) | 31% | $14,526 |
| 2018 | 104 | 31 | None | 41% | $15,879 |
| 2017 | 141 | 39 | None | 43% | $19,061 |
| 2016 | 160 | 43 | None | 42% | $20,022 |
| 2015 | 158 | 27 | None | 40% | $14,970 |
| 2014 | 138 | 32 | 0% (0) | 42% | $13,083 |
| 2013 | 129 | 26 | None | 54% | $16,471 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Estradiol | 40 | $4,755 | $119 |
| Yuvafem | 11 | $2,608 | $237 |
| Fluconazole | 19 | $238 | $13 |
2022: 5 drugs
| Estradiol | 55 | $6,938 | $126 |
| Premarin | 14 | $4,268 | $305 |
| Yuvafem | 11 | $3,391 | $308 |
| Progesterone | 13 | $686 | $53 |
| Fluconazole | 15 | $132 | $9 |
2021: 4 drugs
| Estradiol | 37 | $5,360 | $145 |
| Premarin | 13 | $3,175 | $244 |
| Fluconazole | 18 | $317 | $18 |
| Nitrofurantoin Mono-Macro | 11 | $119 | $11 |
2020: 3 drugs
| Premarin | 20 | $6,498 | $325 |
| Estradiol | 56 | $5,715 | $102 |
| Fluconazole | 16 | $241 | $15 |
2019: 3 drugs
| Premarin | 17 | $4,595 | $270 |
| Estradiol | 54 | $2,966 | $55 |
| Valacyclovir | 13 | $737 | $57 |
2018: 4 drugs
| Premarin | 25 | $6,375 | $255 |
| Prempro | 11 | $2,509 | $228 |
| Estradiol | 13 | $1,012 | $78 |
| Valacyclovir | 16 | $642 | $40 |
2017: 4 drugs
| Premarin | 35 | $7,013 | $200 |
| Prempro | 16 | $4,228 | $264 |
| Valacyclovir | 33 | $1,226 | $37 |
| Estradiol | 17 | $781 | $46 |
2016: 4 drugs
| Premarin | 29 | $6,086 | $210 |
| Prempro | 13 | $2,954 | $227 |
| Valacyclovir | 36 | $1,612 | $45 |
| Estradiol | 14 | $695 | $50 |
2015: 5 drugs
| Premarin | 31 | $4,147 | $134 |
| Prempro | 12 | $2,062 | $172 |
| Valacyclovir | 33 | $1,464 | $44 |
| Vivelle-Dot | 13 | $1,320 | $102 |
| Estradiol | 24 | $433 | $18 |
2014: 4 drugs
| Premarin | 14 | $3,263 | $233 |
| Vivelle-Dot | 19 | $1,654 | $87 |
| Valacyclovir | 21 | $1,222 | $58 |
| Estradiol | 29 | $952 | $33 |
2013: 5 drugs
| Premarin | 30 | $6,399 | $213 |
| Prempro | 14 | $1,942 | $139 |
| Valacyclovir | 16 | $1,268 | $79 |
| Vivelle-Dot | 14 | $935 | $67 |
| Progesterone | 12 | $234 | $20 |
Money from drug and device companies
$307 in 2025
| 2025 | 3 | 3 | None | $307 |
| 2024 | 2 | 5 | None | $291 |
| 2023 | 2 | 14 | None | $1,944 |
| 2022 | 2 | 19 | None | $3,357 |
| 2021 | 3 | 4 | None | $265 |
| 2020 | 2 | 3 | None | $61 |
| 2019 | 5 | 8 | None | $174 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Globus Medical | Rise | $167 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $111 | 1 payment
|
| Hologic Sales and Service | Aptima | $29 | 1 payment
|
See all 3 published payments
| Intuitive Surgical | Meals · 2025-09-09 | Da Vinci Surgical System | $111 |
| Globus Medical | Meals · 2025-07-17 | Rise | $167 |
| Hologic Sales and Service | Meals · 2025-05-20 | Aptima | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $291
| Intuitive Surgical | Da Vinci Surgical System | $231 | 3 payments
|
| Hologic Sales and Service | Acessa Provu System | $61 | 2 payments
|
2023: $1,944
| Intuitive Surgical | Da Vinci Surgical System | $1,768 | 11 payments
|
| NuVasive | Xlif | $176 | 3 payments
|
2022: $3,357
| Intuitive Surgical | Da Vinci Surgical System | $1,836 | 15 payments
|
| Stryker | Spy-Phi System | $1,520 | 4 payments
|
2021: $265
| NuVasive | Alif | $150 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $93 | 2 payments
|
| AbbVie | Lo Loestrin Fe | $22 | 1 payment
|
2020: $61
| AbbVie | Liletta | $46 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $15 | 1 payment
|
2019: $174
| Intuitive Surgical | Da Vinci Surgical System | $62 | 1 payment
|
| Allergan | Lo Loestrin Fe | $42 | 3 payments
|
| AbbVie | Orilissa | $36 | 2 payments
|
| Edwards Lifesciences | Clearsight System | $23 | 1 payment
|
| Avion Pharmaceuticals | Balcoltra | $11 | 1 payment
|
Professional record
- NPI
- 1730144072
- Licence
- CA G81367California G81367: Current · expires 2027-04-30
- Trained
- Medical College of Pennsylvania, 1993
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 15151 National Ave, Los Gatos, CA, 95032
- NPI first listed
- 2006-04-19
- NPI last updated
- 2007-07-09
This is when the NPI record was last certified, not a medical board exam.